CARPRODOLOR 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

CARPROFEN FOR VETERINARY USE

제공처:

Le Vet Beheer B.V.

ATC 코드:

QM01AE91

INN (국제 이름):

CARPROFEN FOR VETERINARY USE

복용량:

50 Mg/Ml

약제 형태:

Solution for Injection

처방전 유형:

POM

치료 그룹:

Bovine

치료 영역:

Carprofen

치료 징후:

N.S.A.I.D

승인 상태:

Authorised

승인 날짜:

2013-04-12

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprodolor 50 mg/ml solution for injection for cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for Injection
Clear, pale, straw coloured liquid.
Per ml:
ACTIVE SUBSTANCE:
Carprofen
50 mg
EXCIPIENT:
Ethanol 96%
0.1 ml
For a full list of excipients, see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 09/05/2016_
_CRN 7023349_
_page number: 1_
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated as an adjunct to antimicrobial therapy to reduce clinical signs in acute infectious respiratory
disease and acute mastitis in cattle.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal impairment.
Do not use in animals suffering from gastro-intestinal ulceration or bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAID’s concurrently or within 24 hours of each other.
As NSAID therapy can be accompanied by GI or renal impairment, adjunctive fluid therapy should be considered
especially in the case of acute mastitis treatment.
SPECIAL PRECAUTIONS TO BE TAK